Valuation : HealthBeacon plc

Market Cap 1.19M 1.02M 961K 877K 1.65M 114M 1.66M 11.4M 4.45M 57.38M 4.47M 4.37M 190M P/E 2021
-7.86x
P/E 2022 -2.89x
Enterprise Value -10.27M -8.85M -8.3M -7.57M -14.27M -981M -14.31M -98.42M -38.4M -495M -38.55M -37.71M -1.64B EV / Sales 2021
35.5x
EV / Sales 2022 12.1x
Free-Float
59.75%
Yield 2021 *
-
Yield 2022 -
3 years 0.06
Extreme 0.0645
1.9
5 years 0.06
Extreme 0.0645
6.24
10 years 0.06
Extreme 0.0645
6.24
Manager TitleAgeSince
Chief Executive Officer 73 2023-09-25
Chief Tech/Sci/R&D Officer - 2012-12-31
Director of Finance/CFO - 2022-12-20
Director TitleAgeSince
Chairman 55 2021-11-21
Director/Board Member 73 2020-09-07
Director/Board Member 73 2021-11-21
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-96.11% 1.29M
+0.79%-3.58%-15.22%+7.72% 195B
+1.40%-2.27%-1.70%+10.84% 117B
+0.25%+1.25%+10.43%+80.01% 61.45B
+0.74%-1.29%-1.79%-32.39% 51.62B
+0.80%-1.18%+27.69%+52.27% 51.03B
+1.71%-1.65%+20.55%-12.18% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+36.66%-17.51% 23.75B
-0.91%-3.06%-6.22%+14.03% 23.41B
Average +0.29%-1.21%+7.82%+0.74% 58.79B
Weighted average by Cap. +0.52%-1.95%+0.41%+14.68%

Financials

2021 2022
Net sales 2.21M 1.91M 1.79M 1.63M 3.08M 212M 3.09M 21.22M 8.28M 107M 8.31M 8.13M 354M 2.25M 1.94M 1.82M 1.66M 3.13M 215M 3.14M 21.57M 8.41M 109M 8.45M 8.26M 360M
Net income -8.21M -7.07M -6.63M -6.05M -11.41M -785M -11.44M -78.69M -30.7M -396M -30.82M -30.15M -1.31B -13.24M -11.41M -10.7M -9.77M -18.4M -1.27B -18.46M -127M -49.53M -639M -49.72M -48.64M -2.12B
Net Debt -26.34M -22.7M -21.28M -19.43M -36.59M -2.52B -36.71M -252M -98.51M -1.27B -98.89M -96.74M -4.21B -11.46M -9.87M -9.26M -8.45M -15.92M -1.09B -15.97M -110M -42.85M -553M -43.02M -42.08M -1.83B
Logo HealthBeacon plc
Healthbeacon Ltd, formerly HealthBeacon plc, is an Ireland-based digital therapeutics company. The Company develops products for managing injectable medications for patients in the home. The Company operates through two segments: Direct-to-Consumer (DTC) and Patient Support Programmes (PSP). Its Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence-driven data analytics. It accesses the end patient through three distinct distribution channels, such as PSP, DTC, and Reimbursed Digital Therapeutics. It delivers technology-enabled waste management solutions. It also develops smart tools for managing medications. The Company operates in over 17 countries primarily across Europe, North America, and the United Kingdom.
Employees
70
  1. Stock Market
  2. Stocks
  3. HBCN Stock